Orion Biotechnology is pursuing many of the same indications as us (oncology, HIV, MS, Stroke and inflammatory Bowel disease). They are HQ in Ontario, Canada so I am not sure that we have patent protection there. I would hope we have the US and Europe approved, but now I am curious as well. Typically, I have only been factoring in US figures for potential patients and indications, but it is a big world out there. Even if lower priced elsewhere potential patients and revenues could dwarf US only figures.....yet we are sitting at .46c and severely undervalued IMO for US only combo HIV.

I’m sure you already looked, but here is there website for others interested.

https://orionbiotechnology.com/